Rasna Therapeutics Stock Analysis
| RASP Stock | USD 0 0 900.00% |
Rasna Therapeutics is overvalued with Real Value of 0.00336 and Hype Value of 0.004. The main objective of Rasna Therapeutics pink sheet analysis is to determine its intrinsic value, which is an estimate of what Rasna Therapeutics is worth, separate from its market price. There are two main types of Rasna Therapeutics' stock analysis: fundamental analysis and technical analysis.
The Rasna Therapeutics pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Rasna |
Rasna Pink Sheet Analysis Notes
About 85.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.31. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Rasna Therapeutics had not issued any dividends in recent years. The entity had 3:1 split on the 20th of September 2016. Rasna Therapeutics, Inc., a leukemia-focused biotechnology company, engages in developing therapeutics for the treatment of acute myeloid leukemia and other forms of leukemia and lymphoma. Rasna Therapeutics, Inc. was founded in 2013 and is headquartered in New York, New York. Rasna Therapeutics operates under Biotechnology classification in the United States and is traded on OTC Exchange.The quote for Rasna Therapeutics is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Rasna Therapeutics contact the company at 646 396 4087 or learn more at https://www.rasna.com.Rasna Therapeutics Investment Alerts
| Rasna Therapeutics generated a negative expected return over the last 90 days | |
| Rasna Therapeutics has some characteristics of a very speculative penny stock | |
| Rasna Therapeutics currently holds 91.97 K in liabilities with Debt to Equity (D/E) ratio of 0.2, which may suggest the company is not taking enough advantage from borrowing. Rasna Therapeutics has a current ratio of 0.04, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Rasna Therapeutics until it has trouble settling it off, either with new capital or with free cash flow. So, Rasna Therapeutics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Rasna Therapeutics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Rasna to invest in growth at high rates of return. When we think about Rasna Therapeutics' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (686.59 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Rasna Therapeutics currently holds about 10.52 K in cash with (312.66 K) of positive cash flow from operations. | |
| Roughly 85.0% of Rasna Therapeutics outstanding shares are owned by corporate insiders |
Rasna Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 12.04 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Rasna Therapeutics's market, we take the total number of its shares issued and multiply it by Rasna Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Rasna Therapeutics, as well as the relationship between them.Rasna Therapeutics Price Movement Analysis
The output start index for this execution was nine with a total number of output elements of fifty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Rasna Therapeutics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Rasna Therapeutics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
About Rasna Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Rasna Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Rasna shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Rasna Therapeutics. By using and applying Rasna Pink Sheet analysis, traders can create a robust methodology for identifying Rasna entry and exit points for their positions.
Rasna Therapeutics, Inc., a leukemia-focused biotechnology company, engages in developing therapeutics for the treatment of acute myeloid leukemia and other forms of leukemia and lymphoma. Rasna Therapeutics, Inc. was founded in 2013 and is headquartered in New York, New York. Rasna Therapeutics operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Rasna Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run FinTech Suite Now
FinTech SuiteUse AI to screen and filter profitable investment opportunities |
| All Next | Launch Module |
Additional Tools for Rasna Pink Sheet Analysis
When running Rasna Therapeutics' price analysis, check to measure Rasna Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rasna Therapeutics is operating at the current time. Most of Rasna Therapeutics' value examination focuses on studying past and present price action to predict the probability of Rasna Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rasna Therapeutics' price. Additionally, you may evaluate how the addition of Rasna Therapeutics to your portfolios can decrease your overall portfolio volatility.